期刊文献+

偏头痛与脑小血管病 被引量:4

Ngtgraine and cerebral small vessel disease
原文传递
导出
摘要 偏头痛与脑小血管病(cerebralsmallvesseldisease,CSVD)是临床上常见的2种神经血管性疾病,其发病机制目前均不清楚。偏头痛会增高CSVD的发病风险,而CSVD也可通过触发皮质扩散性抑制等机制引起偏头痛发作。两者之间的关系是相互和复杂的,且受多种因素的影响,这种潜在关系的机制尚不十分明确。随着研究的深入,有关偏头痛与CSVD之间关系的报道日益增多。文章总结了偏头痛和CSVD的病碑牛理学机制及二者之间的相关件。 Migraine and cerebral small vessel disease (CSVD) are 2 common neurovascular diseases in clinical practice. Their pathogeneses are still not clear. Migraine may increase the risk of CSVD, and CSVD can also cause migraine attacks by triggering cortical spreading depression and other mechanisms. The relationship between the two diseases is mutual and complex, and is influenced by a variety of factors, but the mechanism of this potential relationship is not yet very clear. With further research, the reports about the relationship between migraine and CSVD are increasing. This article summarizes the pathophysiological mechanisms of migraine and CSVD and the correlation between both.
出处 《国际脑血管病杂志》 2017年第12期1114-1117,共4页 International Journal of Cerebrovascular Diseases
基金 河南省科技创新人才项目(201004125)
关键词 脑小血管疾病 偏头痛症 皮质扩散抑制 磁共振成像 危险因素 Cerebral Small Vessel Diseases Migraine Disorders Cortical Spreading Depression Magnetic Resonance Imaging Risk Factors
  • 相关文献

参考文献8

二级参考文献201

  • 1Buzzi MG,Tassorelli C.Experimental models of migraine[J].Handb Clin Neurol,2010,97:109-123.
  • 2Pardutz A,Szatmári E,Vecsei L,et al.Nitroglycerin-Induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan[J].Cephalalgia,2004,24(6):439-445.
  • 3Costa A,Ravaglia S,Sances G,et al.Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline Levels[J].Cephalalgia,2003,23(6):407-413.
  • 4Offenhauser N,Zinck T,Hoffmann J,et al.CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion[J].Cephalalgia,2005,25(3):225-236.
  • 5Gupta S,Villal6n CM.The relevance ofpreclinical research models for the development of antimigraine drugs:focus on 5-HT(1B/1D)and CGRP receptors[J].Pharmacol Ther,2010,128(1):170-190.
  • 6Nagata E,Shibata M,Hamada J,et al.Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period[J]. Headache,2006,46(4):592-596.
  • 7Wang X,Fang Y,Liang J,et al.Elective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine[J].Headache,2010,50(4):579-587.
  • 8Hoskin KL,Goadsby PJ.Exposure and isolation of the superior sagittal sinus elicits Fos in the trigeminal nucleus caudalis and dorsal hom of the cervical spinal cord:How long should you wait[J].Brain Res,1999,824(1):133-135.
  • 9May A,Shepheard SL,Knorr M,et al.Retinal plasma extravasation in animals but not in humans:implications for the pathophysiology of migraine[J].Brain,1998,Pt 7:1231-1237.
  • 10Hoskin KL,Bulmer DC,Lasalandra M,et al.Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation[J].J Anat,2001,198(Pt 1):29-35.

共引文献86

同被引文献22

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部